Ulcerative Colitis Clinical Trials in Southlake, Texas

4 studies are recruiting for ulcerative colitis in Southlake, Texas right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis

    This is a multicenter, randomized, double-blind, placebo-controlled Phase 3 maintenance study to evaluate the efficacy and safety of duvakitug in participants with moderately to severely active Ulcerative Colitis (UC). Study details include: The study duration may be up to 286 weeks including: * 40…

    Stage
    Phase 3
    Ages
    16 to 80
    Site
    Texas Digestive Disease Consultants, PLLC. dba GI Alliance - Southlake - Corporate Office - Site Number: 8400101, Southlake, Texas
    Locations
    55 in total
    Run by
    Sanofi

    See if you can join NCT07185009 on ClinicalTrials.gov

  2. A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis

    This is a Phase 2, multicenter, proof-of-concept platform study in adult participants with moderately to severely active ulcerative colitis (UC). The primary goal of the study is to assess the efficacy and safety of multiple interventions following intravenous (IV) induction and subcutaneous (SC) m…

    Stage
    Phase 2
    Ages
    18 to 75
    Site
    Site 008, Southlake, Texas
    Locations
    267 in total
    Run by
    Spyre Therapeutics, Inc.

    See if you can join NCT07012395 on ClinicalTrials.gov

  3. An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis

    This is a multinational, multicenter, randomized, double-blind, placebo-controlled, Phase 3 induction study to evaluate the efficacy and safety of duvakitug in participants with moderately to severely active Ulcerative Colitis (UC). Study details include: The study duration may be up to 35 weeks wi…

    Stage
    Phase 3
    Ages
    16 to 80
    Site
    Texas Digestive Disease Consultants, PLLC. dba GI Alliance - Southlake - Site Number: 8400101, Southlake, Texas
    Locations
    219 in total
    Run by
    Sanofi

    See if you can join NCT07184996 on ClinicalTrials.gov

  4. A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)

    The main aim of this study is to learn about the effect of treatment with vedolizumab IV (vedolizumab) together with tofacitinib in adults with moderate and severe ulcerative colitis (UC). Another aim is to learn about treatment with Vedolizumab alone after the double treatment. All participants wi…

    Stage
    Phase 4
    Ages
    18 to 65
    Site
    Texas Digestive Disease Consultants (TDDC), Southlake, Southlake, Texas
    Locations
    46 in total
    Run by
    Takeda

    See if you can join NCT06095128 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.